Company profile
Synendos Therapeutics AG
Barfüsserplatz 3
4051 Basel
Switzerland
4051 Basel
Switzerland
therapeutics
small molecules
drug development
Biotech
Synendos aims to develop breakthrough safe and effective therapies for neuropsychiatric disorders through modulation of a new drug target that enables restoration of natural functioning of the brain.
Contact
